GAM
NVO

GuardCap Asset Management’s Novo Nordisk NVO Stock Holding History

GuardCap Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,221
Closed -$1.28M – 28
2025
Q4 		$1.28M Sell
25,221
-114
-0.4% -$5.83K 0.03% 25
2025
Q3 		$1.41M Buy
25,335
+155
+0.6% +$9.07K 0.03% 25
2025
Q2 		$1.74M Sell
25,180
-203
-0.8% -$13.8K 0.03% 25
2025
Q1 		$1.76M Buy
25,383
+4,933
+24% +$407K 0.03% 24
2024
Q4 		$1.76M Sell
20,450
-56
-0.3% -$6.06K 0.03% 25
2024
Q3 		$2.44M Sell
20,506
-97
-0.5% -$12.9K 0.03% 24
2024
Q2 		$2.94M Sell
20,603
-251
-1% -$33.3K 0.04% 21
2024
Q1 		$2.68M Sell
20,854
-14,943
-42% -$1.78M 0.03% 20
2023
Q4 		$3.7M Sell
35,797
-329
-0.9% -$32.5K 0.05% 20
2023
Q3 		$3.29M Sell
36,126
-5,134
-12% -$452K 0.05% 19
2023
Q2 		$3.34M Sell
41,260
-14,786
-26% -$1.21M 0.04% 20
2023
Q1 		$4.46M Sell
56,046
-1,384
-2% -$98.1K 0.06% 19
2022
Q4 		$3.89M Sell
57,430
-5,698
-9% -$334K 0.06% 19
2022
Q3 		$3.15M Hold
63,128
– – 0.05% 19
2022
Q2 		$3.52M Sell
63,128
-1,316
-2% -$73K 0.05% 21
2022
Q1 		$3.58M Sell
64,444
-1,296
-2% -$66.5K 0.05% 21
2021
Q4 		$3.68M Sell
65,740
-2,296
-3% -$124K 0.05% 24
2021
Q3 		$3.27M Buy
68,036
+11,490
+20% +$555K 0.05% 26
2021
Q2 		$2.37M Sell
56,546
-2,884
-5% -$112K 0.03% 27
2021
Q1 		$2M Sell
59,430
-3,492
-6% -$124K 0.04% 28
2020
Q4 		$2.2M Sell
62,922
-1,996
-3% -$69K 0.04% 26
2020
Q3 		$2.25M Buy
64,918
+2,962
+5% +$98.7K 0.07% 25
2020
Q2 		$2.03M Buy
61,956
+6,516
+12% +$208K 0.08% 23
2020
Q1 		$1.67M Sell
55,440
-2,506
-4% -$74.6K 0.1% 24
2019
Q4 		$1.68M Sell
57,946
-2,056
-3% -$56.9K 0.1% 25
2019
Q3 		$1.55M Buy
60,002
+3,584
+6% +$90.6K 0.11% 24
2019
Q2 		$1.44M Sell
56,418
-130
-0.2% -$3.21K 0.12% 24
2019
Q1 		$1.48M Sell
56,548
-8,142
-13% -$200K 0.18% 24
2018
Q4 		$1.49M Buy
64,690
+44,442
+219% +$988K 0.29% 22
2018
Q3 		$477K Buy
+20,248
New +$494K 0.11% 21

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

GuardCap Asset Management's NVO Position: Q1 2026 in Review

GuardCap Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 25,221 shares — an estimated $1.28M sold.

GuardCap Asset Management first reported a position in NVO in Q3 2018 and held it in 30 quarters. The position peaked at $4.46M in Q1 2023. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • GuardCap Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • GuardCap Asset Management sold 25,221 Novo Nordisk shares in Q1 2026, an estimated $1.28M.
  • GuardCap Asset Management first reported a position in Novo Nordisk in Q3 2018 and held it in 30 quarters.
  • GuardCap Asset Management's Novo Nordisk position peaked at $4.46M in Q1 2023.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on GuardCap Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.